 | Forbes - Business |
| |
Current Headlines | Most Read | Archives |
|
| |
 |
Mammogram Debate Shows Why Reform Will Fail (20 November 04:14) |
| Why can't we control costs? Because experts who write perfectly reasonable guidelines get branded death panels. |
| |
|
ObamaCare A Glimmer Of Hope For Cost Control (19 November 11:13) |
| The Senate's tax on Cadillac plans could save billions. |
| |
|
Pilots Spring For Less (19 November 01:34) |
| Cirrus CEO Brent Wouters on a shift in buying habits sparked by the recession. |
| |
|
Answering The Vytorin Question (18 November 04:30) |
| Merck scores a PR win at a cardiology conference, but that doesn't mean its cholesterol drugs are effective. |
| |
|
Freelancers Vs ObamaCare (18 November 12:03) |
| One-size-fits-all insurance reform could stamp out innovation that's already providing coverage and controlling costs. |
| |
|
New Heart Pump Extends Lives (17 November 08:50) |
| Device offers hope to the sickest heart failure patients. |
| |
|
Too Many Mammograms (17 November 03:35) |
| Women can safely wait until age 50 to start getting them, an expert panel says. Get ready for the fireworks. |
| |
|
Another Vytorin Mess For Merck (16 November 04:30) |
| A new study, though flawed, inflicts more damage on the company's Zetia and Vytorin cholesterol pills. |
| |
|
Layoffs Sting Big Pharma (13 November 04:30) |
| Merger-related cuts at Merck and Pfizer show how the mighty drug industry has fallen. |
| |
|
GMs Marketing Czar (13 November 04:31) |
| Vice Chairman Bob Lutz pitted his Cadillac against all comers and got the best of them. |
| |
|
Good Medicine When to Say No to Your Doctor (13 November 03:10) |
| How much of the $2.5 trillion we spend on health care goes down the drain for tests and treatments that don't help, run up the bill and may even cause harm? |
| |
|
Powerful Speaking The Obama Way (12 November 04:30) |
| Three tips for delivering a message effectively like the President. |
| |
|
The Copenhagen Master Plan (12 November 03:15) |
| Denmark readies for 15,000 to descend for the climate change conference. |
| |
|
AMA Uneasy In Support Of ObamaCare (06 November 02:35) |
| The doctors group is pushing for reform to include a hike in Medicare reimbursements, but Congress may not play along. |
| |
|
Embraer Commercial To Private (04 November 09:23) |
| CEO Frederico Curado on the jet manufacturer's strategy during the downturn. |
| |
|
Climate Change And Copenhagen (04 November 04:30) |
| A global consensus on carbon pricing is key for the conference's success. |
| |
|
Why Health Insurance Charges Are Going Up (04 November 03:24) |
| Despite strong earnings, HMOs are planning steep premium increases for next year. |
| |
|
Why Health Insurance Charges Are Going Up (04 November 03:24) |
| Despite strong earnings, HMOs are planning steep premium increases for next year. |
| |
|
Genomics No Longer A Failure (02 November 09:30) |
| Mapping the human genome produced far more hype than drugs. That's starting to change. |
| |
|
Genomics No Longer A Failure (02 November 09:30) |
| Mapping the human genome produced far more hype than drugs. That's starting to change. |
| |
|
Amgens Anemic Results (31 October 07:10) |
| The company's best-selling Aranesp drug doubles the risk that kidney patients will suffer a stroke. |
| |
|
Amgens Anemic Results (31 October 07:10) |
| The company's best-selling Aranesp drug doubles the risk that kidney patients will suffer a stroke. |
| |
|
Living Without Blockbusters (30 October 01:30) |
| Sanofi-Aventis' Christopher Viehbacher is slashing R&D and moving into emerging countries. |
| |
|
Living Without Blockbusters (30 October 01:30) |
| Sanofi-Aventis' Christopher Viehbacher is slashing R&D and moving into emerging countries. |
| |
|
Healing Power (30 October 05:50) |
| Ultrasound is said to heal chronic wounds that don't respond to other treatments. |
| |
|
Healing Power (30 October 05:50) |
| Ultrasound is said to heal chronic wounds that don't respond to other treatments. |
| |
|
Cancer Beats AstraZeneca (28 October 11:53) |
| Company pulls application for a promising experimental drug. |
| |
|
Hefty Side Effect For Kids On Antipsychotics (28 October 03:20) |
| Study finds troubling weight gains in children taking brand-name psychiatric drugs. |
| |
|
Reviving Tysabri (28 October 02:29) |
| The drug's inventor believes a new test might identify people who are less at risk for a deadly side effect. |
| |
|
Swine Flu Shot Gets Mexican Test (20 October 02:30) |
| A vaccine for the 2009 H1N1 influenza virus made in insect cells could be approved as early as next year. |
| |
|
Poacher Joins Gamekeepers (19 October 01:27) |
| The FDA appoints Peter Lurie, a major critic, to its Office of Policy. |
| |
|
Biotechs Back From The Dead (16 October 03:30) |
| The financial crisis was supposed to annihilate small companies, but many survived. |
| |
|
Cobra Ache (15 October 08:30) |
| Poor insurance companies: Too many sick patients are signing up for coverage. |
| |
|
Medtronics Passion Play (14 October 11:49) |
| Medical device maker to test stent as alternative to Viagra. |
| |
|
Little Turnaround For Big Pharma (14 October 11:00) |
| Drug stocks have sat out the rally so far, but with bargain basement valuations, that may be about to change. |
| |
|
Onyx To Buy Drugmaker For $276 Million (12 October 04:30) |
| The potential payoff from the purchase of tiny Proteolix is another big-selling cancer treatment. |
| |
|
Pfizer Suspends Lung Cancer Study (09 October 11:04) |
| The news is another setback for Pfizer as it makes a big push into cancer drugs. |
| |
|
The Cyber Cure (09 October 03:30) |
| From computer modeling to hospital robots, can information technology fix health care? |
| |
|
Wired Medicines Silent Giant (09 October 03:30) |
| The hottest company in the electronic medical records industry is a secretive Wisconsin outfit called Epic Systems. |
| |
|
The Disease Machine (09 October 03:30) |
| Can software synthesize what we know about human biology into one clear picture? Stephen Friend thinks so. |
| |
|
Health Record Gold Rush (09 October 03:30) |
| Want to know what it's like in one of the country's most favored industries? Talk to Allscripts' Glen Tullman. |
| |
|
R2D2 Has Your Pills (09 October 03:30) |
| Drug-dispensing robots and smart medicine cabinets are helping to improve patient care. |
| |
|
The Cybercure (09 October 03:30) |
| From computer modeling to hospital robots, can information technology fix health care? |
| |
|
Cancer Man (02 October 05:10) |
| Patrick Soon-Shiong and one of cancer's biggest riddles. |
| |
|
A Long And Deadly Wait (30 September 03:30) |
| Sabril could help babies with brain-destroying seizures. So why did it take so long to approve? |
| |
|
Abbotts Solvay Deal Dont Get Too Excited (28 September 08:05) |
| The $6.6 billion purchase is about financial engineering, not acquiring new drugs. |
| |
|
Dendreon Starts Growing Up (25 September 11:20) |
| An clear-eyed analyst meeting marks a turning point for the drugmaker. |
| |
|
Strange Bedfellows In The Baucus Brawl (23 September 10:43) |
| Medicare privatization has been a fiscal failure, yet it's now being hailed by ObamaCare opponents. Huh? |
| |
|
Sorry No Magic Pill For Weight Loss (18 September 09:08) |
| A new obesity drug is safe, but it barely works. Will anyone use it? |
| |
|
A New Look At Alzheimers (18 September 03:50) |
| Have researchers been barking up the wrong tree? |
|
